|
|
|
Monday, 02 August 2010
|
Sagent Pharmaceuticals announces two new FDA approvals: SUMATRIPTAN Succinate Injection and ROCURONIUM Bromide Injection
|
|
Thursday, 01 July 2010
|
FDA approves Sagent Pharmaceuticals' HEPARIN Sodium Injection, USP
|
|
Wednesday, 12 May 2010
|
Sagent Pharmaceuticals announces FDA approval of BACITRACIN for Injection, USP
|
|
Tuesday, 04 May 2010
|
Sagent Pharmaceuticals and Actavis enter into exclusive U.S. development, supply and marketing collaboration for a portfolio of specialty injectable pharmaceutical products
|
|
Thursday, 22 April 2010
|
Sagent Pharmaceuticals announces U.S. FDA tentative approval of additional ADENOSINE Injection, USP vial presentations
|
|
Wednesday, 21 April 2010
|
Sagent Pharmaceuticals announces FDA approval of METOPROLOL Tartrate Injection, USP
|
|
Monday, 19 April 2010
|
Sagent Pharmaceuticals announces FDA approval of MESNA Injection
|
|
Wednesday, 14 April 2010
|
Sagent Pharmaceuticals announces FDA approval of GRANISETRON Hydrochloride Injection, USP
|
|
Thursday, 08 April 2010
|
Sagent Pharmaceuticals raises $40 million in two tranches of a series B financing
|
|
Monday, 08 February 2010
|
Sagent Pharmaceuticals announces FDA approval of LABETALOL Hydrochloride Injection, USP
|
|
Tuesday, 19 January 2010
|
Sagent Pharmaceuticals launches PAMIDRONATE Disodium Injection
|
|
Tuesday, 01 December 2009
|
Sagent Pharmaceuticals bolsters antibiotics offering with two product launches
|
|
Monday, 23 November 2009
|
Sagent Pharmaceuticals to present at Piper Jaffray Health Care Conference
|
|
Monday, 26 October 2009
|
Sagent Pharmaceuticals to present at two upcoming financial conferences
|
|
Wednesday, 30 September 2009
|
Sagent Pharmaceuticals launches VINORELBINE INJECTION, USP
|
|
Wednesday, 16 September 2009
|
Sagent Pharmaceuticals to present at UBS Global Life Sciences Conference
|
|
Tuesday, 01 September 2009
|
Sagent Pharmaceuticals announces launch of ADENOSINE INJECTION, USP, in 6 mg per 2 ml single dose vials
|
|
Thursday, 27 August 2009
|
Sagent Pharmaceuticals announces launch of FLUCONAZOLE INJECTION in premix ready-to-use IV bags
|
|
Wednesday, 05 August 2009
|
Sagent Pharmaceuticals announces launch of first two oncolytic products: FLUDARABINE PHOSPHATE FOR INJECTION, USP and EPIRUBICIN HYDROCHLORIDE INJECTION
|
|
Tuesday, 04 August 2009
|
Sagent Pharmaceuticals launches ONDANSETRON IN 5% DEXTROSE INJECTION in premix ready-to-use IV bags
|
|
Friday, 19 June 2009
|
Sagent Pharmaceuticals Enters Into a $15 Million Revolving Credit Facility
|
|
Thursday, 04 June 2009
|
Sagent Pharmaceuticals to Present at 8th Annual Needham Biotechnology & Medical Technology Conference
|
|
Wednesday, 20 May 2009
|
Sagent Pharmaceuticals announces extension of series A financing
|
|
Thursday, 26 March 2009
|
Sagent Pharmaceuticals announces U.S. FDA approval of AZITHROMYCIN FOR INJECTION
|
|
Monday, 09 February 2009
|
Sagent Pharmaceuticals announces expansion of Cefazolin product line to include CEFAZOLIN FOR INJECTION, USP in 500 mg single-dose vial
|
|
Friday, 07 November 2008
|
Sagent Pharmaceuticals announces presentations at upcoming Lazard Capital Markets and Piper Jaffray Healthcare conferences
|
|
Thursday, 25 September 2008
|
Sagent Pharmaceuticals acquires rights to multi-chamber syringe technology and launches device division
|
|
Thursday, 04 September 2008
|
Sagent completes $30 million series a financing extension
|
|
Friday, 25 July 2008
|
Sagent Pharmaceuticals launches AMIODARONE HCL INJECTION, USP
|
|
Thursday, 24 July 2008
|
Sagent Pharmaceuticals launches CEFTAZIDIME FOR INJECTION, USP
|
|
Wednesday, 16 July 2008
|
Sagent Pharmaceuticals launches CEFTRIAXONE, USP, and CEFUROXIME FOR INJECTION, USP
|
|
Wednesday, 14 May 2008
|
Sagent Pharmaceuticals provides US$20,000 in aid to earthquake-devastated areas in central China
|
|
Thursday, 08 May 2008
|
Spectrum Pharmaceuticals announces sale of injectable generic drugs to Sagent Pharmaceuticals, Inc.
|
|
Monday, 24 March 2008
|
Sagent Pharmaceuticals launches CEFEPIME FOR INJECTION, USP
|
|
Wednesday, 19 March 2008
|
Sagent Pharmaceuticals launches CIPROFLOXACIN INJECTION, USP, 5% Dextrose Premix Bag
|
|
Wednesday, 12 March 2008
|
Sagent Pharmaceuticals launches CEFAZOLIN FOR INJECTION, USP
|
|
Tuesday, 29 January 2008
|
Sagent Pharmaceuticals Inc. to present at Merrill Lynch Global Pharmaceutical, Biotechnology and Medical device conference
|
|
Wednesday, 28 November 2007
|
Sagent Pharmaceuticals launches full-line of prefilled 6 mg and 12 mg ADENOSINE syringes
|
|
Monday, 26 November 2007
|
Sagent Pharmaceuticals, Inc. and Astral Pharmaceutical Industries announce collaboration for developing and manufacturing injectable antibiotics
|
|
Tuesday, 30 October 2007
|
Sagent Pharmaceuticals, Inc. and Strides Arcolab Limited announce collaboration to develop and market more than 25 products in the United States
|
|
Sunday, 28 October 2007
|
Sagent Pharmaceuticals, Inc. to present at CIBC world markets 18th annual healthcare conference
|
|
Wednesday, 26 September 2007
|
Sagent Pharmaceuticals, Inc. completes $53 million series a financing
|
| |
|
Results 1 - 42 of 42
|
